Mark Zolman, MD
Physical Medicine & Rehabilitation · Fort Wayne, INNPI 1467455436
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Abbott at 36.7% of the total. Reporting peaked in 2020 at $1,151 and has fallen 85.9% since, to $163 in 2025.
Across 62 payments — averaging $36.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$821
- Stimwave Technologies Incorporated$379
- Medtronic$257
- AbbVie$191
- Collegium Pharmaceutical, Inc.$148
- Tersera Therapeutics LLC$109
- plus $336 from 11 others
What the payments were for
- Food & beverage$2,240100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 7 | $821 |
| Stimwave Technologies Incorporated | 1 | $379 |
| Medtronic(2 entities) | 8 | $257 |
| AbbVie(2 entities) | 11 | $191 |
| Collegium Pharmaceutical, Inc. | 11 | $148 |
| Tersera Therapeutics LLC | 6 | $109 |
| Johnson & Johnson | 2 | $59 |
| Pfizer | 3 | $45 |
| IBSA Pharma Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Painteq LLC | 2 | $29 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Bioventus LLC | 1 | $28 |
| Redhill Biopharma Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,240 in reported general payments places this provider in the 80th percentile of 140 physical medicine & rehabilitation providers in Indiana.
See all physical medicine & rehabilitation providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $791 |
| Pregabalin | 13 | $770 |
| Meloxicam | 17 | $57 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Fort Wayne
- Christina WalzFort Wayne$503K
- Sayed WaheziFort Wayne$161K
- David StenslandFort Wayne$24K
- Daniel RothFort Wayne$10K
- Robert KinneFort Wayne$5K
- Thomas LazoffFort Wayne$3K
- Marc Larsen-HallockFort Wayne$2K
- Audrey SofairFort Wayne$1K
- David LutzFort Wayne$735
- Shashank DaveIndianapolis$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.